Vinorelbine and haematotoxicity Patient Reports February 09, 2010

Vinorelbine Side Effects Report #4924570-X
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haematotoxicity, neutropenia. Vinorelbine dosage: 30 MG/M**2;IV. Patient recovered.

Vinorelbine Side Effects Report #4924575-9
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haematotoxicity, neutropenia. Vinorelbine dosage: 30 MG/M**2;IV. Patient recovered.

Vinorelbine Side Effects Report #4924579-6
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: asthenia, haematotoxicity. Vinorelbine dosage: 30 MG/M2**2;IV. Patient recovered.

Vinorelbine Side Effects Report #4924606-6
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haematotoxicity, skin toxicity. Vinorelbine dosage: 35 MG/M**2; IV. Patient recovered.


Vinorelbine Side Effects Report #4924681-9
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haematotoxicity, neutropenia. Vinorelbine dosage: 30 MG/M**2; IV. Patient recovered.

Vinorelbine Side Effects Report #4948476-5
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haematotoxicity, mucosal inflammation. Vinorelbine dosage: 30 MG/M**2; IV. During the same period patient was treated with PEGYLATED LIPOSOMAL DOXORUBICIN. Patient recovered.

Vinorelbine Side Effects Report #4948483-2
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haematotoxicity, neutropenia. Vinorelbine dosage: 30 MG/M**2; IV. During the same period patient was treated with PEGYLATED LIPOSOMAL DOXORUBICIN. Patient recovered.